A single psychedelic trip may cause physical changes in the brain that could explain why some people report psychological benefits from the experience, a small study suggests. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. The research, published Tuesday in Nature Communications, focused on psilocybin, the psychedelic compound … Read more
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing FDA grants quick review for 3 psychedelic drug trials 02:00 UP NEXT Trump signs order to speed up review of psychedelic drugs for mental health treatment 03:14 Google sued over Gemini’s alleged role in man’s suicide 04:55 Plaintiff’s … Read more
The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. It’s the latest move by the Trump administration signaling a shift in policy toward treatments that also give users a high — coming a day after the Justice Department said … Read more
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing Trump signs order to accelerate access to psychedelic drug treatments 01:25 UP NEXT ‘He’s chasing people out’: President Trump criticizes Mamdani’s tax policies 00:34 ‘I have the right to disagree with the pope,’ Trump says 02:19 Blanche calls … Read more
Watch: Trump signs executive order easing U.S. restrictions on psychedelic research – CBS News Watch CBS News President Trump signed an executive order Saturday that eases restrictions on the research of the psychedelics including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder. Source link
President Trump has signed an executive order to ease restrictions on the psychedelic ibogaine, signaling the administration’s willingness to further U.S. research into the drug, which is used in some countries to treat post-traumatic stress disorder. Mr. Trump was joined by health officials including Health and Human Services Secretary Robert F. Kennedy Jr. and podcaster … Read more
A psychedelic used in some countries to treat post-traumatic stress disorder is expected to get a closer examination from the federal government on its safety and effectiveness, sources told CBS News. The White House is drafting an executive order that would signal the Trump administration’s willingness to further U.S. research into a drug called ibogaine. … Read more